65 results
6-K
EX-99.2
VALN
Valneva SE
26 Mar 24
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
6:44am
, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines as well as certain third-party
6-K
EX-99.1
VALN
Valneva SE
26 Mar 24
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
6:44am
on providing either first-, best- or only-in-class vaccine solutions.
We have a strong track record, having advanced multiple vaccines from early R&D
6-K
EX-99.1
VALN
Valneva SE
20 Mar 24
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
12:52pm
across R&D pipeline
Approval of single-shot chikungunya vaccine IXCHIQ® in the United States (U.S.)The world’s first and only vaccine to address … an estimated 20-30% reduction in third-party sales as a result of anticipated supply constraints.
In 2024, the Company anticipates lower R&D expenses than
6-K
EX-99.1
2eni630j
18 Mar 24
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed
6:44pm
6-K
EX-99.1
fike15
4 Mar 24
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
4:39pm
6-K
EX-99.1
fgonq
29 Feb 24
Current report (foreign)
3:00pm
6-K
EX-99.1
oso1zrj 0iucl
15 Feb 24
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance
6:51am
6-K
EX-99.1
0790a s5ddblbc
5 Feb 24
Valneva Announces Sale of Priority Review Voucher for $103 Million
6:05am
6-K
EX-99.1
vypy2
10 Jan 24
Current report (foreign)
12:42pm
6-K
EX-99.1
6utebsnq1y
8 Jan 24
Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum
8:00am
6-K
EX-99.1
81july 3crwjozzdwdz
29 Dec 23
Valneva Provides Updated 2023 Financial Guidance
5:13pm
6-K
EX-99.1
fcji nvkxua114i
21 Dec 23
Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors
3:57pm
6-K
EX-99.1
3t8hves5w2fm
5 Dec 23
Current report (foreign)
8:50am
6-K
EX-99.2
9l2c1i uvjz
5 Dec 23
Current report (foreign)
8:50am
6-K
EX-99.1
ci2smtwm5a4qbssj4s
27 Nov 23
Current report (foreign)
12:03pm
6-K
EX-99.1
dmrg2admh33a 4yw
15 Nov 23
Valneva Announces the Availability of Documentation for its Extraordinary General Meeting including Planned Changes to its Future Board of Directors
1:12pm
6-K
EX-99.1
my0q0yi9bkergpwhx3
13 Nov 23
Current report (foreign)
6:10am
6-K
EX-99.2
z9st5 806sy0
13 Nov 23
Current report (foreign)
6:10am